Filing Details
- Accession Number:
- 0001181431-14-018063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-06 17:11:00
- Reporting Period:
- 2014-05-02
- Filing Date:
- 2014-05-06
- Accepted Time:
- 2014-05-06 16:11:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1329010 | Laurent Chardonnet | Experimental Station Route 141 &Amp; Henry Clay Road Wilmington DE 19880 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-02 | 14,594 | $9.41 | 18,405 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-05-02 | 19,406 | $9.41 | 37,811 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-05-02 | 34,000 | $51.55 | 3,811 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2014-05-02 | 14,594 | $0.00 | 14,594 | $9.41 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-05-02 | 19,406 | $0.00 | 19,406 | $9.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-01-20 | No | 4 | M | Direct | |
| 0 | 2017-01-20 | No | 4 | M | Direct |
Footnotes
- Beginning January 21, 2010, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Represents weighted average sale price. Actual sales prices ranged from $51.25-$51.85.
- Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
Billionaire Hedge Funds
